North America Artificial Intelligence (AI) in Drug Discovery Market to 2032
Overview
The North America Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a 55.41 USD Billion by 2032 and is projected to grow at a CAGR of 95.26% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.41
Forecast, 2032 (USD Billion)
55.41
CAGR, 2024 - 2032
95.26%
Report Coverage
North America
North America Artificial Intelligence (AI) in Drug Discovery Market 2018-2032 USD Billion
North America Artificial Intelligence (AI) in Drug Discovery Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.41 USD Billion
- Projected Market Size (2032): 55.41 USD Billion
- CAGR (2025-2032): 95.26%
Key Findings of North America Artificial Intelligence (AI) in Drug Discovery Market
- The North America Artificial Intelligence (AI) in Drug Discovery Market was valued at 1.41 USD Billion in 2024.
- The North America Artificial Intelligence (AI) in Drug Discovery Market is likely to grow at a CAGR of 95.26% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Small Molecule in Drug Type Segment accounted for the largest share of the market with a revenue of 1.09 USD Billion
- The fastest growing segment Novel Drug Candidates in Application Segment grew Fastest with a CAGR of 107.13% during the forecast period from 2024 to 2032.
North America Artificial Intelligence (AI) in Drug Discovery Market Scope
North America Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
Offering
- Services
- Software
Application
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
Drug Type
- Large Molecule
- Small Molecule
Technology
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
Indication
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
End Use
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
North America Artificial Intelligence (AI) in Drug Discovery Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.41 USD Billion |
| Market Value in 2032 | 55.41 USD Billion |
| CAGR (2025-2032) | 95.26% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Offering,Application,Drug Type,Technology,Indication,End Use |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 1.41 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,151.46 USD Million in 2024.
Segments and Scope
-
North America Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Offering
- Software is the largest segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 907.08 USD Billion in the year 2024.
- Services is the Fastest growing segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 91.85 % in forecast period 2025-2032.
-
North America Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Application
- Novel Drug Candidates is the largest segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 427.61 USD Billion in the year 2024.
- Novel Drug Candidates is the Fastest growing segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 107.13 % in forecast period 2025-2032.
-
North America Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Drug Type
- Small Molecule is the largest segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 1.09 USD Billion in the year 2024.
- Small Molecule is the Fastest growing segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 96.10 % in forecast period 2025-2032.
-
North America Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Technology
- Machine Learning (ML) is the largest segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 720.89 USD Billion in the year 2024.
- Machine Learning (ML) is the Fastest growing segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 98.12 % in forecast period 2025-2032.
-
North America Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Indication
- Immuno-Oncology is the largest segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 592.35 USD Billion in the year 2024.
- Immuno-Oncology is the Fastest growing segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 98.68 % in forecast period 2025-2032.
-
North America Artificial Intelligence (AI) in Drug Discovery Market to 2032, By End Use
- Contract Research Organizations is the largest segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 658.19 USD Billion in the year 2024.
- Contract Research Organizations is the Fastest growing segment in North America Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 100.48 % in forecast period 2025-2032.
North America Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis
North America Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation Offering,Application,Drug Type,Technology,Indication,End Use.
North America Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.41(Revenue in USD Billion) in 2020.
North America Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 95.26% during the forecast period of 2024 to 2032.
The Small Molecule segment is expected to dominate the North America Artificial Intelligence (AI) in Drug Discovery Market, holding a largest market share of 1.09 USD Billion in 2024
North America Artificial Intelligence (AI) in Drug Discovery Market Scope
North America Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
Offering
- Services
- Software
Application
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
Drug Type
- Large Molecule
- Small Molecule
Technology
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
Indication
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
End Use
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Frequently Asked Questions
The North America Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation Offering,Application,Drug Type,Technology,Indication,End Use.
North America Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.41(Revenue in USD Billion) in 2020.
North America Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 95.26% during the forecast period of 2024 to 2032.
The estimated market value of the North America Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 55.41 (USD Billion).
North America Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Frequently Asked Questions
The North America Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation Offering,Application,Drug Type,Technology,Indication,End Use.
North America Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.41(Revenue in USD Billion) in 2020.
North America Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 95.26% during the forecast period of 2024 to 2032.
The estimated market value of the North America Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 55.41 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.